11897708

pubmed:Citation

4

Because caspase-3 is considered a primary executioner of apoptosis and has been implicated as a mediator of luteal regression, we hypothesized that corpora lutea (CL) derived from caspase-3 null mice would exhibit a delayed onset of apoptosis during luteal regression, when compared with CL derived from wild-type (WT) mice. To test this hypothesis, ovulation was synchronized in immature (postpartum d 24-27) WT and caspase-3-deficient female littermates by exogenous gonadotropins. Individual CL were isolated by manual dissection, 30 h after ovulation, and placed in organ culture dishes in the absence of serum and growth factors. At the time of isolation (0 h) and after 24, 48, and 72 h in culture, the CL were removed and assessed for the presence of processed (active) caspase-3 enzyme and for apoptosis by multiple criteria. There was no evidence of active caspase-3 enzyme or apoptosis in either WT or caspase-3-deficient CL before culture. However, CL derived from the WT mice exhibited a time-dependent increase in the level of active caspase-3 and apoptosis during culture. By comparison, CL derived from caspase-3-deficient mice, cultured in parallel, failed to exhibit any detectable active caspase-3 and showed attenuated rates of apoptosis. To extend these findings derived from ex vivo culture experiments, ovaries were collected from WT and caspase-3 null female littermates at 2, 4, or 6 d post ovulation, and the occurrence of apoptosis within the CL was analyzed. Whereas ovaries of WT mice had only residual luteal tissue at d 6 post ovulation, ovaries collected from caspase-3-deficient mice retained many CL, at d 6 post ovulation, that were similar in size to those observed in the early luteal phase of WT mice. Importantly, there was no dramatic increase in apoptosis in CL of caspase-3-deficient mice at any time point examined post ovulation, indicating that the involution process had indeed been delayed. In contrast, the levels of progesterone declined regardless of genotype. These data provide the first direct evidence that caspase-3 is functionally required for apoptosis to proceed normally during luteal regression. However, caspase-3 is not a direct mediator of the decrease in steroidogenesis associated with luteolysis.

eng

AIM

MEDLINE

0013-7227

Print

NLM

1495-501

pubmed-meshheading:11897708-Animals, pubmed-meshheading:11897708-Apoptosis, pubmed-meshheading:11897708-Caspase 3, pubmed-meshheading:11897708-Caspases, pubmed-meshheading:11897708-Corpus Luteum, pubmed-meshheading:11897708-DNA, pubmed-meshheading:11897708-DNA Fragmentation, pubmed-meshheading:11897708-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:11897708-Female, pubmed-meshheading:11897708-Immunohistochemistry, pubmed-meshheading:11897708-In Situ Nick-End Labeling, pubmed-meshheading:11897708-Mice, pubmed-meshheading:11897708-Mice, Knockout, pubmed-meshheading:11897708-Organ Culture Techniques, pubmed-meshheading:11897708-Ovary, pubmed-meshheading:11897708-Ovulation, pubmed-meshheading:11897708-Progesterone, pubmed-meshheading:11897708-Rats

Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum.

Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't